Biocartis NV - Company & Market Research Reports

Biocartis employs approximately 300 people and is headquartered in Mechelen, Belgium. Biocartis develops novel diagnostic technology platforms. The company produces molecular platforms for sample preparation of nucleic acids, amplification, detection, and generation. The company's proprietary MDx Idylla platform is a fully automated, real time system which offers highly-reliable molecular information from any biological sample in virtually any setting. Idylla addresses the growing demand for personalized medicine by allowing fast and effective treatment selection and treatment progress monitoring.

World In Vitro Diagnostics (IVD) Market Bundle: Molecular Diagnostics (Microbiology, Oncology, Blood, Prenatal, Inherited, Others), Cancer Diagnostics (HPV, ISH, Cytometry, PSA, FOB, Others), Infectious Diseases (ID/AST, POC, HAIs, STDs, Other) - Product Thumbnail Image

World In Vitro Diagnostics (IVD) Market Bundle: Molecular Diagnostics (Microbiology, Oncology, Blood, Prenatal, Inherited, Others), Cancer Diagnostics (HPV, ISH, Cytometry, PSA, FOB, Others), Infectious Diseases (ID/AST, POC, HAIs, STDs, Other)

  • Report
  • 2100 Pages
From
The World Market for Tissue Diagnostics and Cell-Based Diagnostics (Histology and Cytology Tests, in situ hybridization (ISH), HPV Tests, Flow Cytometry, Digital Pathology/Image Cytometry, Hematology Cell Assays, Immunohistochemistry, CTC and Other - Product Thumbnail Image

The World Market for Tissue Diagnostics and Cell-Based Diagnostics (Histology and Cytology Tests, in situ hybridization (ISH), HPV Tests, Flow Cytometry, Digital Pathology/Image Cytometry, Hematology Cell Assays, Immunohistochemistry, CTC and Other

  • Report
  • 433 Pages
From
The World Market for Cancer Diagnostics, 6th Edition (Histology [ISH, IHC, HPV, Pap], Flow Cytometry, PSA, CEA, Liquid Biopsy, FOB and Other Rapid, Image Cytometry, Sequencing, Digital Pathology, Molecular Assays) - Product Thumbnail Image

The World Market for Cancer Diagnostics, 6th Edition (Histology [ISH, IHC, HPV, Pap], Flow Cytometry, PSA, CEA, Liquid Biopsy, FOB and Other Rapid, Image Cytometry, Sequencing, Digital Pathology, Molecular Assays)

  • Report
  • 861 Pages
From
The World Market for Molecular Diagnostics, 7th Edition (Infectious Disease, Cancer, NAT Blood Screening, Transplantation, Histology/Cytology, Inherited Diseases) - Product Thumbnail Image

The World Market for Molecular Diagnostics, 7th Edition (Infectious Disease, Cancer, NAT Blood Screening, Transplantation, Histology/Cytology, Inherited Diseases)

  • Report
  • 353 Pages
From
The World Market for Molecular Diagnostics, 6th Edition (Microbiology, Oncology, Blood Screening and Typing, Prenatal, Inherited Diseases, Coagulation, Organ Transplant, PCR, Sequencing, cfDNA, CTC, in situ hybridization, Others) - Product Thumbnail Image

The World Market for Molecular Diagnostics, 6th Edition (Microbiology, Oncology, Blood Screening and Typing, Prenatal, Inherited Diseases, Coagulation, Organ Transplant, PCR, Sequencing, cfDNA, CTC, in situ hybridization, Others)

  • Report
  • 1032 Pages
From
World Market for Molecular Diagnostics, 5th. Edition (Infectious Disease, Oncology, Blood Screening, Pre-Natal and Other Areas) - Product Thumbnail Image

World Market for Molecular Diagnostics, 5th. Edition (Infectious Disease, Oncology, Blood Screening, Pre-Natal and Other Areas)

  • Report
  • 880 Pages
From
Japan In Vitro Diagnostics (IVD) Market Outlook to 2024 - Clinical Chemistry, Genetic Testing, Hematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture - Product Thumbnail Image

Japan In Vitro Diagnostics (IVD) Market Outlook to 2024 - Clinical Chemistry, Genetic Testing, Hematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture

  • Report
  • 511 Pages
From
The Worldwide Market for Liquid Biopsy (by Analyte [ctDNA, cfDNA, Other], by Application - Screening/Drug Monitoring/Diagnostic, by Region [US, Europe, Asia, ROW] and by Type of Cancer) - Product Thumbnail Image

The Worldwide Market for Liquid Biopsy (by Analyte [ctDNA, cfDNA, Other], by Application - Screening/Drug Monitoring/Diagnostic, by Region [US, Europe, Asia, ROW] and by Type of Cancer)

  • Report
  • 210 Pages
From
2017 IVD Market Research Bundle (The Worldwide Market for In Vitro Diagnostic Tests, NGS, Companion, US IVD) - Product Thumbnail Image

2017 IVD Market Research Bundle (The Worldwide Market for In Vitro Diagnostic Tests, NGS, Companion, US IVD)

  • Report
  • 2600 Pages
From
Companion Diagnostics Markets (Cancer, Cardiovascular and Blood, Metabolic, Infection, Neurological, Others) - Product Thumbnail Image

Companion Diagnostics Markets (Cancer, Cardiovascular and Blood, Metabolic, Infection, Neurological, Others)

  • Report
  • 298 Pages
From
Molecular Diagnostics for Infectious Disease. Markets, Strategies and Trends. Volume & Price Forecasts by Pathogen and by Country. With Multiplex and Point of Care Market Analysis, Executive Guides and Customization. 2019 to 2023 - Global Version - Product Thumbnail Image

Molecular Diagnostics for Infectious Disease. Markets, Strategies and Trends. Volume & Price Forecasts by Pathogen and by Country. With Multiplex and Point of Care Market Analysis, Executive Guides and Customization. 2019 to 2023 - Global Version

  • Report
  • 306 Pages
From
Polymerase Chain Reaction (PCR) - A Global Market Overview - Product Thumbnail Image

Polymerase Chain Reaction (PCR) - A Global Market Overview

  • Report
  • 344 Pages
From
Liquid Biopsy Markets By Cancer Type By Diagnosis, Monitoring & Recurrence Testing. 2019-2023 W. Historical Data Including Screening Market Potential Size With Executive And Consultant Guides - Product Thumbnail Image

Liquid Biopsy Markets By Cancer Type By Diagnosis, Monitoring & Recurrence Testing. 2019-2023 W. Historical Data Including Screening Market Potential Size With Executive And Consultant Guides

  • Report
  • 285 Pages
From
Liquid Biopsy Markets by Cancer Type, by Diagnosis, Monitoring & Recurrence Testing 2019-2023 - Historical Data Including Screening Market Potential Size with Executive and Consultant Guides - Product Thumbnail Image

Liquid Biopsy Markets by Cancer Type, by Diagnosis, Monitoring & Recurrence Testing 2019-2023 - Historical Data Including Screening Market Potential Size with Executive and Consultant Guides

  • Report
  • 292 Pages
From
Liquid Biopsy Research Tools, Services and Diagnostics: Global Markets - Product Thumbnail Image

Liquid Biopsy Research Tools, Services and Diagnostics: Global Markets

  • Report
  • 282 Pages
From
Companion Diagnostics: Technologies and Markets - Product Thumbnail Image

Companion Diagnostics: Technologies and Markets

  • Report
  • 352 Pages
From
The Top 250 Developers of In-Vitro Diagnostics Tests for Cancer, Cardiovascular & Infectious Diseases - Product Thumbnail Image

The Top 250 Developers of In-Vitro Diagnostics Tests for Cancer, Cardiovascular & Infectious Diseases

  • Report
  • 438 Pages
From
The Top 200 Developers of In-Vitro Diagnostics Tests for Cancer & Infectious Diseases - Product Thumbnail Image

The Top 200 Developers of In-Vitro Diagnostics Tests for Cancer & Infectious Diseases

  • Report
  • 360 Pages
From
PCR Market for Life Sciences and Diagnostics (qPCR & dPCR, TMA and Other NAAT) - Product Thumbnail Image

PCR Market for Life Sciences and Diagnostics (qPCR & dPCR, TMA and Other NAAT)

  • Report
  • 427 Pages
From
Companion Diagnostics - Global Strategic Business Report - Product Thumbnail Image

Companion Diagnostics - Global Strategic Business Report

  • Report
  • 278 Pages
From
Loading Indicator
adroll